Ovoca Bio | OVG - Operating Profit


Ovoca Bio reported EUR-1.16M in Operating Profit for its fiscal semester ending in June of 2025.





Operating Profit Change Date
Akebia Therapeutics USD -5.45M 9.4M Dec/2025
Alaunos Therapeutics USD -1.01M 175K Mar/2026
ALKERMES USD -48.28M 37.33M Mar/2026
Avita Medical AUD -10.41M 742K Dec/2025
Dianthus Therapeutics USD -46.53M 23.01M Mar/2026
Great Western Mining Corporation EUR -486.58K 43.28K Jun/2025
Ionis Pharmaceuticals USD -118M 97M Mar/2026
IQVIA Holdings USD 565M 2.11B Mar/2026
Malin Corporation EUR -1.1M 400K Dec/2024
Moderna USD -1.39B 531M Mar/2026
Organon & Co USD 266M 49M Mar/2026
Ovoca Bio EUR -1.16M 4.48M Jun/2025
Revvity USD 82.77M 63.06M Mar/2026
Tectonic Therapeutic USD -27.3M 5.78M Mar/2026
Viatris USD -20.2M 137.3M Mar/2026
Xeris Pharmaceuticals USD 7.92M 8.86M Mar/2026